Aguilar Moses Victor Javier 4
4 · PROCTER & GAMBLE Co · Filed May 6, 2025
Insider Transaction Report
Form 4
Aguilar Moses Victor Javier
Chf Rsch, Dev & Innov Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2025-05-05−10,520→ 0 totalExercise: $80.29From: 2019-02-28Exp: 2026-02-27→ Common Stock (10,520 underlying) - Sale
Common Stock
2025-05-05$158.67/sh−10,520$1,669,200→ 25,181.569 total - Exercise/Conversion
Common Stock
2025-05-05$80.29/sh+10,520$844,651→ 35,701.569 total - Award
Restricted Stock Units
2025-02-18+11.676→ 85.058 total→ Common Stock (11.676 underlying)
Holdings
- 6,259.851(indirect: By Trust)
Common Stock
- 428.603(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock and shares acquired through the issuer's dividend reinvestment plan.
- [F2]Weighted average price of the shares sold. The price range was $158.65 to $158.74. Full information regarding the number of shares sold at each separate price available upon request.
- [F3]Reflects adjustment to PST through March 31, 2025.
- [F4]Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
- [F5]These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.